Php365 - Trends and Characteristics of Managed Access Agreements Approved by Nice

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2864
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Php296 - Managed Access Agreements (Maas) and Continuing Data Collection After Provisional Positive Recommendation From the National Institute for Health and Care Excellence (Nice)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pmu31 - A Review of Managed Access Agreements (Maas) and Patient Access Schemes (Pass) in England

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Government Insists NHS Pays for Drugs Approved by NICE

BMJ
2001English

Adoption of Managed Entry Agreements in Established and Emerging Markets

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Managed Trade: The US-Mexico Sugar Suspension Agreements

Canadian Journal of Economics
EconomicsEconometrics
2019English

What Principles Should Govern the Use of Managed Entry Agreements?

International Journal of Technology Assessment in Health Care
Health Policy
2011English

Can Early Access Support Continued Access? The Relationship Between Eams and Nice

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Nature of Endpoints in Market Access Agreements

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Php353 - Romanian Experience With Managed Entry Agreements for Drugs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy